Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;1(2):90-95.
doi: 10.15420/cfr.2015.1.2.90.

Fluid Management in Patients with Chronic Heart Failure

Affiliations

Fluid Management in Patients with Chronic Heart Failure

Pierpaolo Pellicori et al. Card Fail Rev. 2015 Oct.

Abstract

Congestion, or fluid overload, is a classic clinical feature of patients presenting with heart failure patients, and its presence is associated with adverse outcome. However, congestion is not always clinically evident, and more objective measures of congestion than simple clinical examination may be helpful. Although diuretics are the mainstay of treatment for congestion, no randomised trials have shown the effects of diuretics on mortality in chronic heart failure patients. Furthermore, appropriate titration of diuretics in this population is unclear. Research is required to determine whether a robust method of detecting - and then treating - subclinical congestion improves outcomes.

Keywords: Diuretics; chronic heart failure; congestion; review; treatment.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. A Simplified Pathophysiology of Pulmonary Oedema or Peripheral Oedema Development in Patients with HFREF or HeFNEF

Similar articles

Cited by

References

    1. Cleland JG, McDonagh T, Rigby AS, et al; National Heart Failure Audit Team for England and Wales. The national heart failure audit for England and Wales 2008–2009. Heart. 2011;97:876–886. - PubMed
    1. Carson PE, Anand IS, Win S, et al. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015;3:429–441. - PubMed
    1. Clark AL, Cleland JG. Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol. 2013;10:156–170. - PubMed
    1. Shoaib A, Waleed M, Khan S, et al. Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. Eur J Heart Fail. 2014;16:1283–1291. - PubMed
    1. Ambrosy AP, Pang PS, Khan S, et al; EVEREST Trial Investigators. Clinical course and predictive value of congestion during hospitalisation in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34:835–843. - PubMed